OBJECTIVE: To determine, in the early stages of suspected clinically significant infection, the independent relationship of the presenting venous lactate level to 28-day in-hospital mortality. DESIGN: Prospective, observational cohort study. SETTING: Urban, university tertiary-care hospital. PATIENTS: One thousand two hundred and eighty seven adults admitted through the emergency department who had clinically suspected infection and a lactate measurement. MEASUREMENTS AND RESULTS: Seventy-three [5.7% (95% CI 4.4-6.9%)] patients died in the hospital within 28 days. Lactate level was strongly associated with 28-day in-hospital mortality in univariate analysis (p<0.0001). When stratified by blood pressure, lactate remained associated with mortality (p<0.0001). Normotensive patients with a lactate level >or=4.0 mmol/l had a mortality rate of 15.0% (6.0-24%). Patients with either septic shock or lactate >or=4.0 mmol/l had a mortality rate of 28.3% (21.3-35.3%), which was significantly higher than those who had neither [mortality of 2.5% (1.6-3.4%), p<0.0001. In a model controlling for age, blood pressure, malignancy, platelet count, and blood urea nitrogen level, lactate remained strongly associated with mortality. Patients with a lactate level of 2.5-4.0 mmol/l had adjusted odds of death of 2.2 (1.1-4.2); those with lactate >or=4.0 mmol/l had 7.1 (3.6-13.9) times the odds of death. The model had good discrimination (AUC=0.87) and was well calibrated. CONCLUSIONS: In patients admitted with clinically suspected infection, the venous lactate level predicts 28-day in-hospital mortality independent of blood pressure and adds significant prognostic information to that provided by other clinical predictors.
OBJECTIVE: To determine, in the early stages of suspected clinically significant infection, the independent relationship of the presenting venous lactate level to 28-day in-hospital mortality. DESIGN: Prospective, observational cohort study. SETTING: Urban, university tertiary-care hospital. PATIENTS: One thousand two hundred and eighty seven adults admitted through the emergency department who had clinically suspected infection and a lactate measurement. MEASUREMENTS AND RESULTS: Seventy-three [5.7% (95% CI 4.4-6.9%)] patients died in the hospital within 28 days. Lactate level was strongly associated with 28-day in-hospital mortality in univariate analysis (p<0.0001). When stratified by blood pressure, lactate remained associated with mortality (p<0.0001). Normotensive patients with a lactate level >or=4.0 mmol/l had a mortality rate of 15.0% (6.0-24%). Patients with either septic shock or lactate >or=4.0 mmol/l had a mortality rate of 28.3% (21.3-35.3%), which was significantly higher than those who had neither [mortality of 2.5% (1.6-3.4%), p<0.0001. In a model controlling for age, blood pressure, malignancy, platelet count, and blood ureanitrogen level, lactate remained strongly associated with mortality. Patients with a lactate level of 2.5-4.0 mmol/l had adjusted odds of death of 2.2 (1.1-4.2); those with lactate >or=4.0 mmol/l had 7.1 (3.6-13.9) times the odds of death. The model had good discrimination (AUC=0.87) and was well calibrated. CONCLUSIONS: In patients admitted with clinically suspected infection, the venous lactate level predicts 28-day in-hospital mortality independent of blood pressure and adds significant prognostic information to that provided by other clinical predictors.
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: Nathan I Shapiro; Richard E Wolfe; Richard B Moore; Eric Smith; Elizabeth Burdick; David W Bates Journal: Crit Care Med Date: 2003-03 Impact factor: 7.598
Authors: Michael A Puskarich; Stephen Trzeciak; Nathan I Shapiro; Alan C Heffner; Jeffrey A Kline; Alan E Jones Journal: Resuscitation Date: 2011-06-23 Impact factor: 5.262
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2008-01-31 Impact factor: 17.440
Authors: Michael W Donnino; Joseph C Miller; Matthew Bivens; Michael N Cocchi; Justin D Salciccioli; Sarah Farris; Shiva Gautam; Donald Cutlip; Michael Howell Journal: Circulation Date: 2012-08-09 Impact factor: 29.690
Authors: Daniel J Henning; Michael A Puskarich; Wesley H Self; Michael D Howell; Michael W Donnino; Donald M Yealy; Alan E Jones; Nathan I Shapiro Journal: Ann Emerg Med Date: 2017-03-03 Impact factor: 5.721
Authors: Ann Chen Wu; James P Kiley; Patricia J Noel; Shashi Amur; Esteban G Burchard; John P Clancy; Joshua Galanter; Maki Inada; Tiffanie K Jones; Jonathan A Kropski; James E Loyd; Lawrence M Nogee; Benjamin A Raby; Angela J Rogers; David A Schwartz; Don D Sin; Avrum Spira; Scott T Weiss; Lisa R Young; Blanca E Himes Journal: Am J Respir Crit Care Med Date: 2018-12-15 Impact factor: 21.405
Authors: Michael W Donnino; Michael N Cocchi; Howard Smithline; Erin Carney; Peter P Chou; Justin Salciccioli; Justin Salciccoli Journal: Nutrition Date: 2010-01 Impact factor: 4.008
Authors: Tim C Jansen; Jasper van Bommel; Paul G Mulder; Johannes H Rommes; Selma J M Schieveld; Jan Bakker Journal: Crit Care Date: 2008-12-17 Impact factor: 9.097